about
Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort study.Cancer risk in patients with chronic obstructive pulmonary diseaseEarly menarche and new onset of asthma: Results from the SAPALDIA cohort study.Is there a differential impact of parity on blood pressure by age?Oral health improvements in Switzerland over 20 years.Colorectal cancer and markers of anemia.Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project.Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project.Use of anti-malarial drugs and the risk of developing eye disorders.Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders.Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations.Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.Reflux disease, gastrointestinal ulcer or weight loss in patients with COPD.Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors.Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.Chronic obstructive pulmonary disease and the risk of cardiovascular diseasesCOPD and the Risk of DepressionThe Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes MellitusIncidence Rates and Trends of Hip/Femur Fractures in Five European Countries: Comparison Using E-Healthcare Records DatabasesTraditional and Digital Biomarkers: Two Worlds Apart?Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control StudyDental care behaviour in SwitzerlandWeight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study
P50
Q37012488-5D3F60CF-DA55-46B9-A3EC-387059B804DEQ37300835-4D1FA725-2A75-4331-BF1C-4251B8E36EB5Q38679679-CB9F421E-69B7-4557-B257-AEDF37E6AB4CQ38977860-D13E9557-457E-46CA-9C90-7C9BAFAB9B1EQ39437882-65498692-5329-466A-9547-E14B57E383E3Q40129256-DC1EC3E8-2A97-4D86-96D6-56F320654551Q40763565-31708E23-7F87-42AC-9BD4-FE76D0C432DBQ41650125-5837A6FD-B6CF-4BEE-82E6-52882A495E13Q41924266-45F84701-F306-4DEC-98C3-5106C3790BB1Q41926277-CED2449A-194B-4311-A333-D9921FDE5DC6Q43244412-7FC8F550-6E3B-40CE-95FC-19DAFEC42200Q45946884-FE1ECC68-E199-460D-B806-E50685A91156Q47431309-FCBAD44D-866F-41A8-8174-F431EBD2DA6CQ49542743-13741F43-9B86-487F-98A1-5286621255D0Q53063796-D50280F3-E19A-4996-8AF0-F812911C85DEQ57950749-68023527-18E4-44C6-834C-F1CCF214D943Q57950792-02FD4A6B-C42C-44AF-A3F8-338D712C74BFQ61068488-0A1F6BC8-AA33-4C11-B396-E19C5203682FQ61068491-A1628379-4F6E-49B0-A282-E7E9596E6991Q89870441-1FD03392-4CA2-4BD7-8D0D-9C3185B66C1CQ91111365-222219FC-B747-4F3D-A010-421720AFE1D4Q91588780-3F2B3FBF-AA36-4C0C-AB50-DB32417EBEB3Q92883063-B3156ADC-68C0-468A-BD5B-AF6D545AEEE0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cornelia Schneider
@ast
Cornelia Schneider
@en
Cornelia Schneider
@es
Cornelia Schneider
@nl
Cornelia Schneider
@sl
type
label
Cornelia Schneider
@ast
Cornelia Schneider
@en
Cornelia Schneider
@es
Cornelia Schneider
@nl
Cornelia Schneider
@sl
prefLabel
Cornelia Schneider
@ast
Cornelia Schneider
@en
Cornelia Schneider
@es
Cornelia Schneider
@nl
Cornelia Schneider
@sl
P106
P21
P31
P496
0000-0001-9628-691X